A clinical metagenomic study of biopsies from Mexican endophthalmitis patients reveals the presence of complex bacterial communities and a diversity of resistance genes
- PMID: 39045243
- PMCID: PMC11261729
- DOI: 10.1099/acmi.0.000639.v3
A clinical metagenomic study of biopsies from Mexican endophthalmitis patients reveals the presence of complex bacterial communities and a diversity of resistance genes
Abstract
Infectious endophthalmitis is a severe ophthalmic emergency. This infection can be caused by bacteria and fungi. For efficient treatment, the administration of antimicrobial drugs to which the microbes are susceptible is essential. The aim of this study was to identify micro-organisms in biopsies of Mexican endophthalmitis patients using metagenomic next-generation sequencing and determine which antibiotic resistance genes were present in the biopsy samples. In this prospective case study, 19 endophthalmitis patients were recruited. Samples of vitreous or aqueous humour were extracted for DNA extraction for metagenomic next-generation sequencing. Analysis of the sequencing results revealed the presence of a wide variety of bacteria in the biopsies. Resistome analysis showed that homologues of antibiotic resistance genes were present in several biopsy samples. Genes possibly conferring resistance to ceftazidime and vancomycin were detected in addition to various genes encoding efflux pumps. Our findings contrast with the widespread opinion that only one or a few bacterial strains are present in the infected tissues of endophthalmitis patients. These diverse communities might host many of the resistance genes that were detected, which can further complicate the infections.
Keywords: endophthalmitis; moxifloxacin; resistome; shotgun metagenomics.
Copyright © 2024 The Authors.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
References
-
- Bowen RC, Zhou AX, Bondalapati S, Lawyer TW, Snow KB, et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. Br J Ophthalmol. 2018;102:1268–1276. doi: 10.1136/bjophthalmol-2017-311051. - DOI - PMC - PubMed
-
- Das T. Endophthalmitis management: stain-culture, empirical treatment, and beyond. Asia Pac J Ophthalmol. 2020;9:1–3. doi: 10.1097/01.APO.0000617904.11979.ae. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources